|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.080 USD | +3.01% |
|
+7.69% | -15.85% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 99.33M 86.79M 80.28M 74.93M 141M 9.39B 142M 954M 371M 4.61B 373M 365M 16.03B | P/E 2026 * |
1.25x | P/E 2027 * | 5.92x |
|---|---|---|---|---|---|
| Enterprise Value | 99.33M 86.79M 80.28M 74.93M 141M 9.39B 142M 954M 371M 4.61B 373M 365M 16.03B | EV / Sales 2026 * |
1.24x | EV / Sales 2027 * | 0.74x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +3.01% | ||
| 1 week | +7.69% | ||
| Current month | +10.00% | ||
| 1 month | +12.41% | ||
| 3 months | +3.36% | ||
| 6 months | -14.92% | ||
| Current year | -15.85% |
| 1 week | 2.81 |  | 3.16 |
| 1 month | 2.53 | | 3.16 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.7 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-01 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-18 | Free | Chief Executive Officer | 475,424 | 1.5318% | ||
| 03-18 | Free | Director | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.01% | +7.69% | +80.12% | -67.38% | 99.33M | |
| +0.42% | -0.40% | +19.65% | -21.46% | 62.05B | |
| -0.84% | -9.93% | +57.21% | +194.41% | 54.52B | |
| -5.75% | +29.50% | +29.50% | +29.50% | 41.55B | |
| -2.96% | +4.99% | -53.01% | -60.20% | 39.06B | |
| +1.59% | +0.54% | +60.08% | -32.06% | 29.02B | |
| -7.22% | +13.84% | +131.18% | -50.74% | 25.38B | |
| +5.54% | +1.65% | +54.12% | +67.44% | 19.62B | |
| -1.05% | -1.44% | -3.02% | +139.59% | 16.89B | |
| +1.04% | +1.28% | +63.17% | +110.01% | 15.89B | |
| Average | -0.59% | +2.73% | +43.90% | +30.91% | 30.41B | |
| Weighted average by Cap. | -1.30% | +0.91% | +34.82% | +37.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.8M 64.56M 60.26M 113M 7.55B 114M 767M 299M 3.71B 300M 293M 12.89B | 134M 117M 108M 101M 190M 12.68B 191M 1.29B 501M 6.23B 504M 493M 21.65B |
| Net income | 90.51M 79.09M 73.16M 68.28M 128M 8.55B 129M 869M 338M 4.21B 340M 332M 14.61B | 21.13M 18.46M 17.08M 15.94M 29.93M 2B 30.15M 203M 78.97M 982M 79.34M 77.62M 3.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 3.080 $ | +3.01% | 538,048 |
| 18/06/26 | 2.990 $ | -2.61% | 372,256 |
| 17/06/26 | 3.070 $ | +4.78% | 689,378 |
| 16/06/26 | 2.930 $ | +2.45% | 375,026 |
| 15/06/26 | 2.860 $ | +3.25% | 463,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
